These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4349136)

  • 41. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 42. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

  • 43. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 44. [Triglyceride level and insulin concentration in plasma following oral glucose administration in patients with primary carbohydrate-induced hypertriglyceridemia].
    Sailer S; Bolzano K; Sandhofer F; Spath P; Braunsteiner H
    Schweiz Med Wochenschr; 1968 Sep; 98(39):1512-8. PubMed ID: 5701068
    [No Abstract]   [Full Text] [Related]  

  • 45. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN; Ghosh P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetic lipemia. A form of acquired fat-induced lipemia.
    Bagdade JD; Porte D; Bierman EL
    N Engl J Med; 1967 Feb; 276(8):427-33. PubMed ID: 6018273
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
    Bielmann P; Brun D; Moorjani S; Gagnon MA; Tétreault L; Lupien PJ
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):166-71. PubMed ID: 192685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
    Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
    J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids.
    Ritland S; Fausa O; Gjone E; Blomhoff JP; Skrede S; Lanner A
    Scand J Gastroenterol; 1975; 10(8):791-800. PubMed ID: 173015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid metabolism in pregnancy. I. Changes in lipoprotein triglyceride and cholesterol in normal pregnancy and the effects of diabetes mellitus.
    Knopp RH; Warth MR; Carrol CJ
    J Reprod Med; 1973 Mar; 10(3):95-101. PubMed ID: 4348501
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV; Nikul'cheva NG
    Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bezafibrate and delayed action etofibrate in hyperlipidemia].
    Lang PD; Vollmar J
    Dtsch Med Wochenschr; 1983 Feb; 108(8):302-5. PubMed ID: 6825604
    [No Abstract]   [Full Text] [Related]  

  • 55. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK
    JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
    [No Abstract]   [Full Text] [Related]  

  • 56. [Familial hyperlipoproteinemia type III].
    Patsch JR; Patsch W; Sailer S; Braunsteiner H
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
    [No Abstract]   [Full Text] [Related]  

  • 57. Benign symmetric lipomatosis (Launois-Bensaude adenolipomatosis) with gout and hyperlipoproteinemia.
    Greene ML; Glueck CJ; Fujimoto WY; Seegmiller JE
    Am J Med; 1970 Feb; 48(2):239-46. PubMed ID: 5416265
    [No Abstract]   [Full Text] [Related]  

  • 58. Independence of myocardial disease in the JCR:LA-corpulent rat on plasma cholesterol concentration.
    Russell JC; Koeslag DG; Amy RM; Dolphin PJ
    Clin Invest Med; 1991 Aug; 14(4):288-95. PubMed ID: 1782727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevalence of hyperlipidemia in a natural community.
    Gibson TC; Whorton EB
    J Chronic Dis; 1973 Apr; 26(4):227-36. PubMed ID: 4351694
    [No Abstract]   [Full Text] [Related]  

  • 60. [Blood insulin in the course of hypertriglyceridemia induced by diet rich in carbohydrates].
    Młyński J; Ciswicka-Sznajderman M
    Pol Arch Med Wewn; 1976 Dec; 56(6):525-33. PubMed ID: 1005176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.